Sr Med Director - Hematology/Oncology(Remote U.S)
Thermo Fisher ScientificSalary not specified
- Full Time
- Senior (5 to 8 years)
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, Radiopharmaceuticals, OncologyIndustries
Requirements
Candidates should possess a Ph.D. in Medical Physics, Nuclear Physics, or a related scientific discipline, along with a strong understanding of nuclear medicine physics and radiopharmaceuticals. Demonstrated experience in dosimetry, imaging, and therapeutic development is essential, and a minimum of 10 years of experience in the field is preferred. Knowledge of oncology and pharmaceutical development processes is highly desirable.
Responsibilities
The Director - Medical Physics - Radiopharmaceuticals will drive the strategy and execution of dosimetry principles and analyses across the Oncology RPT portfolio, collaborating with PK scientists and modelers. They will proactively lead and manage the delivery of analyses through internal or outsourced dosimetry platforms, contribute to study documentation, deliver subject matter expertise, support decision-making for Health Authorities, and collaborate with cross-functional teams and external vendors. Furthermore, this role will serve as an in-house expert for building Nuclear Physics/Medical Physics capabilities and provide modeling & dosimetry subject area expertise across imaging PK Sciences and RPT initiatives, and process data to guide business development opportunities.
Skills
Nuclear Medical Physics
Dosimetry
Imaging Modalities
Image Evaluation
Dosimetry Estimation
Clinical Protocols
Regulatory Documentation
Health Authority Communication
Cross-Functional Collaboration
Eli Lilly and Company
Develops and delivers prescription medicines globally
About Eli Lilly and Company
Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.
Key Metrics
Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees